Arvate, H. R. (2025) “Major clinical outcomes of the action of the co-agonist tirzepatide to liraglutide and semaglutide in the treatment of obesity and type 2 diabetes mellitus: a systematic review”, International Journal of Nutrology, 18(1). doi: 10.54448/ijn25102.